Regeneron Pharmaceuticals, Inc. (REGN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Regeneron Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 17.92x | 17.42x | 23.70x | 17.81x | 8.27x | 14.80x |
| P/B Ratio | 2.58x | 2.62x | 3.61x | 3.41x | 3.56x | 4.71x |
| P/S Ratio | 5.63x | 5.41x | 7.14x | 6.35x | 4.15x | 6.12x |
| Profitability | ||||||
| Gross Margin | 85.4% | 86.1% | 82.9% | 86.0% | 83.1% | 84.0% |
| Operating Margin | 24.9% | 28.1% | 33.2% | 44.2% | 55.7% | 42.1% |
| Net Margin | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% | 41.3% |
| EBITDA Margin | 40.6% | 37.4% | 35.8% | 43.2% | 60.2% | 48.3% |
| Liquidity | ||||||
| Current Ratio | 4.13x | 4.73x | 5.69x | 5.06x | 3.56x | 3.63x |
| Quick Ratio | 3.39x | 3.95x | 4.94x | 4.29x | 3.07x | 2.91x |
| Leverage | ||||||
| Debt/Equity | 0.09x | 0.09x | 0.10x | 0.12x | 0.14x | 0.24x |
YoY = year-over-year change. Source: FMP..